Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schwarzinger

Showing results (211-220 of 359) with videos related to

Pageof 36
Sort By:
Transplantation|September 17, 2004
Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistanceDominique Desvaux, Michaël Schwarzinger, Myriam Pastural, et al.
Annals of Hematology|May 1, 1991
Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemiaI Pabinger, P Bettelheim, R Dudczak, et al.
Health Policy (Amsterdam, Netherlands)|April 29, 2008
Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance systemThierry Pistone, Michaël Schwarzinger, Pierre Chauvin, et al.
Thrombosis and Haemostasis|December 7, 1992
Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosisI Schwarzinger, M Stain-Kos, P Bettelheim, et al.
Cancer Genetics and Cytogenetics|February 13, 2003
Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clonesDaniel Heintel, Berthold Streubel, Natascha Welzel, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acidBirgit Steinmetz, Hubert Hackl, Eva Slabáková, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 23, 2012
An inhibitory peptide derived from the α-subunit of the epithelial sodium channel (ENaC) shows a helical conformationSilke Haerteis, Daniel Schaal, Felix Brauer, et al.
British Journal of Haematology|April 1, 1995
PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemiaG Mitterbauer, M Födinger, R Scherrer, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2009
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)R Simanek, R Vormittag, C Ay, et al.
Wiener Klinische Wochenschrift|January 22, 1988
Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patientsI Schwarzinger, P Bettelheim, A Chott, et al.
Pageof 36

Showing results (211-220 of 359) with videos related to

Sort By:
Pageof 36
Transplantation|September 17, 2004
Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistanceDominique Desvaux, Michaël Schwarzinger, Myriam Pastural, et al.
Annals of Hematology|May 1, 1991
Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemiaI Pabinger, P Bettelheim, R Dudczak, et al.
Health Policy (Amsterdam, Netherlands)|April 29, 2008
Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance systemThierry Pistone, Michaël Schwarzinger, Pierre Chauvin, et al.
Thrombosis and Haemostasis|December 7, 1992
Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosisI Schwarzinger, M Stain-Kos, P Bettelheim, et al.
Cancer Genetics and Cytogenetics|February 13, 2003
Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clonesDaniel Heintel, Berthold Streubel, Natascha Welzel, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acidBirgit Steinmetz, Hubert Hackl, Eva Slabáková, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 23, 2012
An inhibitory peptide derived from the α-subunit of the epithelial sodium channel (ENaC) shows a helical conformationSilke Haerteis, Daniel Schaal, Felix Brauer, et al.
British Journal of Haematology|April 1, 1995
PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemiaG Mitterbauer, M Födinger, R Scherrer, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2009
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)R Simanek, R Vormittag, C Ay, et al.
Wiener Klinische Wochenschrift|January 22, 1988
Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patientsI Schwarzinger, P Bettelheim, A Chott, et al.
Pageof 36